|
Volumn 46, Issue 9, 2007, Pages 803-804
|
Thiopurine treatment in inflammatory bowel disease [1]
a a b c d a,d |
Author keywords
[No Author keywords available]
|
Indexed keywords
AZATHIOPRINE;
MERCAPTOPURINE;
THIOPURINE METHYLTRANSFERASE;
BREAST MILK;
DRUG BLOOD LEVEL;
DRUG EXPOSURE;
DRUG METABOLISM;
DRUG RESEARCH;
DRUG USE;
ENTERITIS;
HUMAN;
LETTER;
PRIORITY JOURNAL;
RISK ASSESSMENT;
TREATMENT CONTRAINDICATION;
6-MERCAPTOPURINE;
ADULT;
ANTIMETABOLITES;
BREAST FEEDING;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FEMALE;
HUMANS;
INFANT;
INFANT, NEWBORN;
INFLAMMATORY BOWEL DISEASES;
MILK, HUMAN;
|
EID: 34548310414
PISSN: 03125963
EISSN: 03125963
Source Type: Journal
DOI: 10.2165/00003088-200746090-00007 Document Type: Letter |
Times cited : (2)
|
References (11)
|